发明名称 |
STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF |
摘要 |
The present invention relates generally to the enantiomers ofpara-hydroxy- milnacipran or congeners thereof. Biological assays revealed that racemic para-hydroxy-milnacipran is approximately equipotent in inhibiting serotonin and norepinephrine uptake (IC50 = 28.6 nM for norepinephrine, IC50 = 21.7 nM for serotonin). Interestingly, (+) para-hydroxy-milnacipran is a more potent inhibitor of norepinephrine uptake than serotonin uptake (IC50 = 10.3 nM for norepinephrine, IC50 = 22 nM for serotonin). In contrast, (-) para-hydroxy-milnacipran is a more potent inhibitor of serotonin uptake compared to norepinephrin uptake (IC50 = 88.5 nM for norepinephrine, IC50 = 40.3 nM for serotonin). The invention also relates to salts and prodrug forms of the aforementioned compounds. In certain embodiments, the compounds of the present invention and a pharmaceutically acceptable excipient are combined to prepare a formulation for administration to a patient. Finally, the present invention relates to methods of treating mammals suffering from various afflictions, e.g., depression, chronic pain, or fibromyalgia, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound of the present invention. |
申请公布号 |
WO2004039320(A3) |
申请公布日期 |
2004.06.24 |
申请号 |
WO2003US33681 |
申请日期 |
2003.10.22 |
申请人 |
COLLEGIUM PHARMACEUTICAL, INC. |
发明人 |
RARIY, ROMAN, V.;HEFFERNAN, MICHAEL;BUCHWALD, STEPHEN, L.;SWAGER, TIMOTHY, M. |
分类号 |
A61K;A61K9/22;A61K31/165;A61K31/195;A61K31/277;A61K31/655;A61K31/695;C07C233/58;C07C237/24 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|